Mohammed Shami in extra-marital affair? Wife Hasin Jahan posts WhatsApp-Facebook pics

Mumbai, Mar 9: The mayhem in domestic stock markets deepened with the BSE Sensex falling over 2,400 points and the Nifty50 trading below 10,400 points.

The plunge in the domestic indices was in line with the global markets on persistent fears of economic impact of the coronavirus epidemic.

Stocks of Reliance Industries registered the biggest fall in over 10 years as it fell to Rs 1,094.95 per share. At 1.34 p.m., it was trading at Rs 1,100, lower by Rs 170.05 or 13.39 per cent from its previous close. The stock fell most since October 2008.

The benchmark index of BSE Sensex was trading at 35,232.67 points, lower by 2,343.95 points or 6.24% from the previous close of 37,576.62 points. 

It had opened at the intra-day high of 36,950.20 and has so far touched a low of 35,109.18.

The Nifty50 on the National Stock Exchange was trading at 10,314.25 points, lower by 675.20 points or 6.14% from the previous close. 

It was a sell-off across sectors, led by financial, metal, energy and IT stocks - which weighed on the markets.

Further, crude oil prices also slumped around 30% on Monday as Organization of Petroleum Exporting Countries (OEPC) failed to agree on an output cut deal, eventually causing Saudi Arabia to cut its prices as it is likely to increase its production. Saudi Arabia's stance has already raised concerns of an all-out price war.

Brent crude futures are currently trading around $34 per barrel.

On Saturday, Saudi Arabia announced massive discounts to its official selling prices for April, and the nation is reportedly preparing to increase its production above the 10 million barrel per day mark, according to reports.

As per analysts, the oil market witnessed the worst price fall on Monday since the 1991 Gulf War.

Melbourne, Mar 7: He will be supporting Australia for sure but former pacer Brett Lee feels an Indian victory in Sunday's T20 Word Cup final could be a "start of a major breakthrough" for the women's game in the cricket-mad country.

India and Australia will lock horns in what is expected to be a blockbuster title clash at the Melbourne Cricket Ground.

"As an Australian, I'd love nothing more than for (Meg) Lanning's team to do the job. But if India were to win the World Cup for the first time, victory would do so much for women's cricket in a country that already adores the sport," Lee wrote in an ICC column.

"This could be the start of a major breakthrough, particularly with the amount of talent that is coming through."

The former speedster said Australia will have to look for ways to counter the in-form 16-year-old Shafali Verma.

"In Shafali Verma, India boast one of the most talented players in the world and you feel that for Australia to win the game, dismissing her will likely be their first job.

"I've been so impressed with the opener - it's staggering to believe she's only 16 with the confidence she has in her own ability and the way she strikes the ball so cleanly.

"She's such good fun to watch and I'm not sure the women's game has seen anyone like her for such a long time."

Shafali has been the star of the tournament, having amassed 161 runs at a strike rate of 161, consistently providing India solid starts, and that was not lost on Lee.

"To be the world's best T20 batter already shows just how far she has progressed in such a short space of time and the experience in this tournament will hold her in good stead for years to come.

"Even with the way she's played in Australia and her fearless brand of cricket, you still get the feeling she has more to come as well."

He reckoned Shafali may have another big score awaiting her.

"She's got a big score in her locker and there's probably no better place to do that than the MCG. Shafali is already a record breaker but if she can steer her side to their first Women's T20 World Cup title at just 16, then the sky really is the limit for her career."

UN, May 26: Countries could see a "second peak" of coronavirus cases during the first wave of the pandemic if lockdown restrictions were lifted too soon, the World Health Organization (WHO) has warned.

Mike Ryan, the WHO's head of emergencies, told a briefing on Monday that the world was "right in the middle of the first wave", the BBC reported.

He said because the disease was "still on the way up", countries need to be aware that "the disease can jump up at any time".

"We cannot make assumptions that just because the disease is on the way down now that it's going to keep going down," Ryan said.

There would be a number of months to prepare for a second peak, he added.

The stark warning comes as countries around the world start to gradually ease lockdown restrictions, allowing shops to reopen and larger groups of people to gather.

Experts have said that without a vaccine to give people immunity, infections could increase again when social-distancing measures are relaxed.

Ryan said countries where cases are declining should be using this time to develop effective trace-and-test regimes to "ensure that we continue on a downwards trajectory and we don't have an immediate second peak".

Also on Monday, Tedros Adhanom Ghebreyesus, WHO Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference.

The developments come as the total number of global COVID-19 cases has increased to 5,508,904, with 346,508 deaths, according to the Johns Hopkins University.